secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001193125-24-266101
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hans Bishop resigns from Lyell Immunopharma Board and Nominating Committee
--------------------------------------------------------------------------

- Hans Bishop resigned from the Board and Nominating Committee effective November 22, 2024.
- Resignation is not the result of any disagreement or dispute with the Company.
- No replacement has been announced; board composition changes accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312524266101/0001193125-24-266101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312524266101/d848587d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-266101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer